| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 1
| Issue : 2 | Page : 68-71 |
|
|
Impact of metabolic and bariatric surgery on liver diseases: Current evidence
Lokesh Agarwal1, Ritvik Chekuri2, Vitish Singla2, Arun Kumar2, Shalimar3, Sandeep Aggarwal2
1 Department of Gastrointestinal Surgery and Liver Transplantation, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
2 Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India
3 Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Dr. Sandeep Aggarwal
Departments of Surgical Disciplines, All India Institute of Medical Sciences, Ansari Nagar, New Delhi
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jbs.jbs_9_22
|
|
|
The obesity pandemic has led to metabolic-associated fatty liver disease as being a major cause of chronic liver disease and liver transplantation worldwide. Metabolic and bariatric surgery (MBS), through a significant and sustained weight loss, has been shown to have a positive impact on both liver steatohepatitis and fibrosis. This review article aims to present and critically appraise the current literature on the impact of MBS on liver disease and highlight its increasing acceptance within the liver transplant community.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
